Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Best Practices, LLC Strategic Benchmarking Research
Best Practices in Medical Education Program Strategy:
Establishing the...
Page | 2
Table of Contents
 Executive Summary pgs. 3-13
 Research Overview pg. 4
 Participating Companies pg. 5
 Medic...
Page | 3
Medical Education Benchmark Research: Objectives,
Methodology & Topics
In an ever-changing industry where patient...
Page | 4
Benchmark Class:
This study engaged 15 leaders supporting medical education at 13 leading life sciences companies...
Page | 5
Medical Education Landscape Varies Greatly Across Sectors
Medical Education requirements, standards and “boundari...
Page | 6
Key Findings & Insights : Structure & Activities
The following key findings and insights emerged from this study....
Page | 7
Q. ProfessionalMedical EducationStructural Approach:Please indicate which structure best describesthe organizatio...
Page | 8
Pharma Relies On Vendors To Create & Deliver Programs
% Respondents
Q. What percentage of your programs are gener...
Page | 9
Q. Contact Information: Please provide the following information, which will be used for classificationpurposesan...
About Best Practices LLC
Page | 11
Best Practices®, LLC is an internationally recognized thought leader in the field of best practice
benchmarking®...
Upcoming SlideShare
Loading in …5
×

Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resources and Activities

194 views

Published on

Bio-pharmaceutical organizations have long relied on medical education programs to provide latest medical knowledge to physicians and other health care professionals. However, recent compliance rules and regulations have tempered the sponsorship of some medical education programs by bio-pharmaceutical companies, as well as some third-party providers of such services.

Best Practices, LLC, undertook benchmarking research to probe emerging medical education trends at top bio-pharmaceutical companies. In particular, this research provides benchmarks on the proper size, structure, activities performed, staffing, and investment for the Medical Education function.

Download Full Report: http://bit.ly/2cf5PYb

Published in: Education
  • Be the first to comment

  • Be the first to like this

Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resources and Activities

  1. 1. Best Practices, LLC Strategic Benchmarking Research Best Practices in Medical Education Program Strategy: Establishing the Right Structures, Resources and Activities to Optimize Biopharmaceutical Education Groups
  2. 2. Page | 2 Table of Contents  Executive Summary pgs. 3-13  Research Overview pg. 4  Participating Companies pg. 5  Medical Education Landscape pg. 6  Changes In Medical Education Within The Last 2-3 Years pg. 7  Key Recommendations pg. 8  Key Findings & Insights pgs. 9-12  Dual Focus of Medical Education pg. 13  Structure & Activities pgs. 14-19  Professional Education Investment Level & Funding Sources pgs. 20-31  Professional Medical Education Staffing & Benchmark pgs. 32-43  Changing Trends & Directions For Medical Education pgs. 44-50  Benchmark Class Demographics pgs. 51-55  About Best Practices LLC pgs. 56-57
  3. 3. Page | 3 Medical Education Benchmark Research: Objectives, Methodology & Topics In an ever-changing industry where patient compliance, efficacy and safety are of the utmost importance, medical education plays pivotal role in informing physicians & health care professionals about the latest medical knowledge. Best Practices, LLC, undertook this benchmarking study to inform those that lead medical education functions on the proper size, resourcing, and structure for this function or group. Topics Covered Research Methodology Research Overview  Medical Education group structure and activities performed  The funding channels utilized by Medical Education groups  Staffing benchmarks for Medical Education groups  Benchmark Medical Education resources, investmentallocation and budgetallocation by region and program type.  Trends in grants to professional societies/associations for accredited and non-accredited education programs  Future trends in Medical Education staffing & investment Best Practices, LLC engaged 15 leaders from 13 top biopharmaceutical companies through a benchmarking survey.This report captures insights from the pharma industry.  New compliance, transparencyrules and regulationshave tempered the sponsorship of some medical education programs by pharma companies, as well as some third-party providers of such services.  This benchmarking study investigatesemerging Medical Education trends at pharmaceutical organizations regardingfunding, program types. It also informs Medical Affairs & Medical Education function leaders on the proper size, resourcing, and structure for this function or group.
  4. 4. Page | 4 Benchmark Class: This study engaged 15 leaders supporting medical education at 13 leading life sciences companies. More than 50% of participants are at the level of director/ senior director and around 20% of participants are managers. More than 80% of participants were from the United States. Universe of Learning: 13 Companies Participated In Study
  5. 5. Page | 5 Medical Education Landscape Varies Greatly Across Sectors Medical Education requirements, standards and “boundaries” are in a state of flux. There are significant differences based on region, size of company, therapeutic area and Medical Device / Bio-pharm perspectives. Factors Shaping MedEd Perspectives Europe Requirements FDA & Safety Pressures Political Pressures Developing Markets Political Pressures U.S. Requirements Clinical & Medical Science Litigation Structural Forces Creating Changes CME Clinical Education – Disease State Awareness Medical Education – Product Specific Medical Tech Biopharma Size of Company Region of World Medical Device Therapeutic Area Operating under CIA
  6. 6. Page | 6 Key Findings & Insights : Structure & Activities The following key findings and insights emerged from this study.  Medical Education Structure Is Predominantly Centralized  More than three-fourths of pharma companies centralize their medical education structure; 46% of them have located their centralized medical education group in the United States.  Medical Education is a part of professional affairs/medical education at 40% of pharma companies. Professionally, medical education is a part of a larger medical affairs group at 93% of pharma companies.  Benchmark Companies Rely Heavily On Outsourcing  Pharma companies heavily rely on outsourcing for developing and deploying medical education programs. They outsource 86% of medical education program development to vendors, while they depend totally on vendors for program deployment and delivery.
  7. 7. Page | 7 Q. ProfessionalMedical EducationStructural Approach:Please indicate which structure best describesthe organizationalapproach of your medical education function and organization. (Choose one) Medical Education Centralized in Headquarter Country Or U.S. Market % Respondents Nearly 80% of companies use a centralized structure to organize their Medical Education groups. This is a significant shift from 2011 when only 58% took a centralized approach. It also appears that many companies have abandoned the idea of a hybrid structure as 27% used this approach in 2011 and none stated that the do now.1 Centralized in headquarters country 33% Centralized in U.S. Market (where U.S. is not the headquarters country) 46% Regional headquarters in U.S. & Europe 7% Decentralized by the product or therapeutic area 7% Other 7% N=15 Professional Medical Education Structural Approach: 1PSM-269 ProfessionalMedicalEducationExcellence:Structures,Resources,Services & PerformanceLevels to OptimizePharmaceuticalEducationGroups,2011
  8. 8. Page | 8 Pharma Relies On Vendors To Create & Deliver Programs % Respondents Q. What percentage of your programs are generated through each of the following talent pools (Each row should add up to 100%). N=7 Pharma participants usually use vendors to develop and deploy medical education programs. In-company % Outsourced % 75th Percentile 0% 100% Mean 14% 86% Median 0% 100% 25th Percentile 0% 100% Medical education program development Outsourced % 100% 100% 100% 100% Medical education program deployment/delivery In sourced / Outsourced
  9. 9. Page | 9 Q. Contact Information: Please provide the following information, which will be used for classificationpurposesand to ensure that you receive your copy of the study deliverable. Universe Of Learning: Insights Drawn From Host Of Pharma Experts % Respondents This research features insights from a range of leaders in medical education functions. More than half of respondents serve as a director / sr. director roles, while around 20% of participants serving as manager. N=15 Other: Research Scientist,Team Lead, Independent Grants for Learning & Change, MSL Excellence Director/ Senior Director 60% Manger 20% Other 20% Participants Designation
  10. 10. About Best Practices LLC
  11. 11. Page | 11 Best Practices®, LLC is an internationally recognized thought leader in the field of best practice benchmarking®. We are a research, consulting, benchmark database, publishing and advisory firm that conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by leveraging the best business practices, operating tactics and winning strategies of world-class companies. 6350 Quadrangle Drive, Suite 200 Chapel Hill, NC 27517 (Phone): 919-403-0251 www.best-in-class.com Learn More About Our Company:

×